IP Library Granted Patent US 7,691,917
Granted Patent B2
US 7,691,917 · App. 11/762,970 · Granted Apr 6, 2010

Silcone-containing prepolymers

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,691,917
App. No.
11/762,970
Granted
Apr 6, 2010
Kind
B2
Abstract

Prepolymers comprising at least one block of Formula II and terminated with a polymerizable ethylenically unsaturated radical are useful in hydrogel materials are disclosed: wherein n, R, R 1 , R 2 and X + are as defined herein.

Claims (68)

1. A prepolymer comprising at least one block of Formula II and terminated with a polymerizable ethylenically unsaturated radical:

wherein n is at least 1, R is independently a monovalent hydrocarbon radical having 1 to 30 carbon atoms which may include ether linkages therebetween or a halogen substituted monovalent hydrocarbon radical having 1 to 20 carbon atoms which may include ether linkages therebetween, a C 1 -C 20 ester group, an ether or polyether-containing group, an ureido group, an amide group, an amine group, a substituted or unsubstituted C 1 -C 30 alkoxy group, a substituted or unsubstituted C 5 -C 30 heteroaryl group, a substituted or unsubstituted C 3 -C 30 heterocyclic ring, a substituted or unsubstituted C 4 -C 30 heterocycloalkyl group, a substituted or unsubstituted C 6 -C 30 heteroarylalkyl group, fluorine or a vinyl group, R 1 is independently a substituted or unsubstituted divalent hydrocarbon radical having 1 to 30 carbon atoms which may include ether linkages therebetween, X + is independently a cationic-containing group and R 2 is a diradical residue of a diisocyanate.

2. The prepolymer of claim 1 , wherein X + is independently a cationic group comprising an ammonium, phosphonium or sulphonium cationic-containing group.

3. The prepolymer of claim 1 , wherein R 1 is a C 1 -C 12 alkylene group optionally substituted with an ether linkage.

4. The prepolymer of claim 1 , wherein R is a C 1 -C 6 alkyl group.

5. The prepolymer of claim 1 , wherein the prepolymer is terminated at two ends with a polymerizable ethylenically unsaturated radical.

6. The prepolymer of claim 1 , wherein the polymerizable ethylenically unsaturated radical is of the formula

wherein R 18 is hydrogen or methyl; R 19 is independently hydrogen, an alkyl radical having 1 to 6 carbon atoms, or a —CO—Y—R 21 radical wherein Y is —O—, —S— or —NH— and R 21 is a divalent alkylene radical having 1 to about 10 carbon atoms; R 20 is an alkyl radical having 1 to about 12 carbon atoms; B denotes —O— or —NH—; Z denotes —CO—, —OCO— or —COO; Ar denotes an aromatic radical having 6 to about 30 carbon atoms; w is 0 to 6; a is 0 or 1; b is 0 or 1; and c is 0 or 1.

7. The prepolymer of claim 1 , which is of Formula III:

wherein n, R, R 1 , R 2 and X + have the aforestated meanings; x is at least about 1 and each A is independently a polymerizable ethylenically unsaturated radical.

8. The prepolymer of claim 7 , wherein each A is independently a polymerizable ethylenically unsaturated radical of the formula

wherein

R 18 is hydrogen or methyl;

R 19 is independently hydrogen, an alkyl radical having 1 to 6 carbon atoms, or a —CO—Y—

R 21 radical wherein Y is —O—, —S— or —NH— and R 21 is a divalent alkylene radical having 1 to about 10 carbon atoms;

R 20 is an alkyl radical having 1 to about 12 carbon atoms;

B denotes —O— or —NH—; Z denotes —CO—, —OCO— or —COO;

Ar denotes an aromatic radical having 6 to about 30 carbon atoms;

w is 0 to 6; a is 0 or 1; b is 0 or 1; and c is 0 or 1.

9. The prepolymer of claim 7 , wherein x is from 1 to about 20.

10. A copolymer comprising a polymerization product of a monomeric mixture comprising one or more of the prepolymers of claim 7 .

11. The copolymer of claim 10 , wherein the monomeric mixture further comprises a hydrophilic monomer, hydrophobic monomer or both.

12. The copolymer of claim 11 , wherein the hydrophilic monomer is selected from the group consisting of 2-hydroxyethylmethacrylate, 2-hydroxyethylacrylate, glyceryl methacrylate; N-vinyl pyrrolidone; N-vinyl-N-methyl acetamide, N,N-dimethyl methacrylamide, N,N-dimethylacrylamide, acrylic acid, methacrylic acid and mixtures thereof.

13. The copolymer of claim 11 , wherein the hydrophobic monomer is a silicone-containing monomer having from 1 to about 20 silicon atoms.

14. The copolymer of claim 13 , wherein the silicone monomer is 3-methacryloxypropyl tris(trimethylsiloxy)silane.

15. The copolymer of claim 11 , wherein the hydrophobic monomer is an aliphatic ring containing monomer selected from the group consisting of isobornyl acrylate, iosbomyl methacrylate, cyclohexyl acrylate, cyclohexyl methacrylate and combinations thereof.

16. The copolymer of claim 10 , having:

a water content of about 30 weight percent and an oxygen permeability greater than about 80 barrers.

17. The copolymer of claim 10 , having:

a water content of about 30 to about 60 weight percent, and an oxygen permeability greater than about 110 barrers.

18. A biomedical device comprising a copolymer of claim 10 .

19. An ophthalmic lens comprising a copolymer of claim 10 .

20. A contact lens comprising a copolymer of claim 10 .

21. A hydrogel comprising a hydrated polymerization product of a monomeric mixture comprising one or more of the prepolymers of claim 7 .

22. The hydrogel of claim 21 , wherein the monomeric mixture further comprises a comonomer.

23. The hydrogel of claim 21 , wherein the monomeric mixture further comprises at least one hydrophilic comonomer selected from the group consisting of an unsaturated carboxylic acid, (meth)acrylic substituted alcohol, vinyl lactam, (meth)acrylamide and combinations thereof.

24. A copolymer comprising a polymerization product of a monomeric mixture comprising one or more of the prepolymers of claim 1 .

25. The copolymer of claim 24 , wherein the monomeric mixture further comprises a hydrophilic monomer, hydrophobic monomer or both.

26. The copolymer of claim 25 , wherein the hydrophilic monomer is selected from the group consisting of 2-hydroxyethylmethacrylate, 2-hydroxyethylacrylate, glyceryl methacrylate; N-vinyl pyrrolidone; N-vinyl-N-methyl acetamide, N,N-dimethyl methacrylamide, N,N-dimethylacrylamide, acrylic acid, methacrylic acid and combinations thereof.

27. The copolymer of claim 25 , wherein the hydrophobic monomer is a silicone-containing monomer having from 1 to about 20 silicon atoms.

28. The copolymer of claim 27 , wherein the silicone monomer is 3-methacryloxypropyl tris(trimethylsiloxy)silane.

29. The copolymer of claim 25 , wherein the hydrophobic monomer is an aliphatic ring containing monomer selected from the group consisting of isobornyl acrylate, isobornyl methacrylate, cyclohexyl acrylate, cyclohexyl methacrylate and combinations thereof.

30. The copolymer of claim 24 , having:

a water content of about 30 weight percent and an oxygen permeability greater than about 80 barrers.

31. The copolymer of claim 24 , having:

a water content of about 30 to about 60 weight percent, and an oxygen permeability greater than about 110 barrers.

32. A biomedical device comprising a copolymer of claim 24 .

33. An ophthalmic lens comprising a copolymer of claim 24 .

34. A contact lens comprising a copolymer of claim 24 .

35. A hydrogel comprising a hydrated polymerization product of a monomeric mixture comprising one or more of the prepolymers of claim 1 .

36. The hydrogel of claim 35 , wherein the monomeric mixture further comprises a comonomer.

37. The hydrogel of claim 35 , wherein the monomeric mixture further comprises at least one hydrophilic comonomer selected from the group consisting of an unsaturated carboxylic acid, (meth)acrylic substituted alcohol, vinyl lactam, (meth)acrylamide and combinations thereof.

38. A prepolymer of Formula IV:

wherein n is at least 1, R is independently hydrogen, a monovalent hydrocarbon radical having 1 to 30 carbon atoms which may include ether linkages therebetween or a halogen substituted monovalent hydrocarbon radicals having 1 to 20 carbon atoms which may include ether linkages therebetween, a C 1 -C 20 ester group, an ether or polyether-containing group, an ureido group, an amide group, an amine group, a substituted or unsubstituted C 1 -C 30 alkoxy group, a substituted or unsubstituted C 5 -C 30 heteroaryl group, a substituted or unsubstituted C 3 -C 30 heterocyclic ring, a substituted or unsubstituted C 4 -C 30 heterocycloalkyl group, a substituted or unsubstituted C 6 -C 30 heteroarylalkyl group, fluorine or a vinyl group, R 1 is independently a substituted or unsubstituted divalent hydrocarbon radical having 1 to 30 carbon atoms which may include ether linkages therebetween, X + is independently a cationic group; and each A′ is independently a polymerizable ethylenically unsaturated organic-containing radical.

39. The prepolymer of claim 38 , wherein X + is independently a cationic group comprising an ammonium, phosphonium or sulphonium cationic group.

40. The prepolymer of claim 38 , wherein each A′ is an isocyanate ethyl methacrylate-containing radical.

41. A copolymer comprising a polymerization product of a monomeric mixture comprising one or more of the prepolymers of claim 38 .

42. A biomedical device comprising a copolymer of claim 41 .

43. An ophthalmic lens comprising a copolymer of claim 41 .

44. A contact lens comprising a copolymer of claim 41 .

45. The copolymer of claim 41 , wherein the monomeric mixture further comprises a hydrophilic monomer, hydrophobic monomer or both.

46. The copolymer of claim 45 , wherein the hydrophilic monomer is selected from the group consisting of 2-hydroxyethylmethacrylate, 2-hydroxyethylacrylate, glyceryl methacrylate; N-vinyl pyrrolidone; N-vinyl-N-methyl acetamide, N,N-dimethyl methacrylamide, N,N-dimethylacrylamide, acrylic acid, methacrylic acid and combinations thereof.

47. The copolymer of claim 45 , wherein the hydrophobic monomer is a silicone-containing monomer having from 1 to about 20 silicon atoms.

48. The copolymer of claim 47 , wherein the silicone monomer is 3-methacryloxypropyl tris(trimethylsiloxy)silane.

49. The copolymer of claim 45 , wherein the hydrophobic monomer is an aliphatic ring containing monomer selected from the group consisting of isobornyl acrylate, isobornyl methacrylate, cyclohexyl acrylate, cyclohexyl methacrylate and combinations thereof.

50. A hydrogel comprising a hydrated polymerization product of a monomeric mixture comprising one or more of the prepolymers of claim 38 .

51. The hydrogel of claim 50 , wherein the monomeric mixture further comprises a comonomer.

52. The hydrogel of claim 50 , wherein the monomeric mixture further comprises at least one hydrophilic comonomer selected from the group consisting of an unsaturated carboxylic acid, (meth)acrylic substituted alcohol, vinyl lactam, (meth)acrylamide and combinations thereof.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
NOTICE OF SUCCESSION OF AGENCY Recorded Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
SECURITY AGREEMENT Recorded Sep 4, 2013
From: BAUSCH & LOMB INCORPORATED
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 031156/0508 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2013
From: CITIBANK N.A., AS ADMINISTRATIVE AGENT
To: WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS INC.); BAUSCH & LOMB INCORPORATED; ISTA PHARMACEUTICALS
Reel/Frame 030995/0444 →
SECURITY AGREEMENT Recorded Aug 6, 2012
From: BAUSCH & LOMB INCORPORATED; EYEONICS, INC.
To: CITIBANK N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 028728/0645 →
RELEASE OF SECURITY INTEREST Recorded Aug 5, 2012
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 028726/0142 →
SECURITY AGREEMENT Recorded May 13, 2010
From: WP PRISM INC.; BAUSCH & LOMB INCORPORATED; B&L CRL, INC.; B&L CRL PARTNERS, L.P.; B & L DOMESTIC HOLDINGS CORP.; B&L FINANCIAL HOLDINGS CORP.; B&L SPAF INC.; B&L VPLEX HOLDINGS, INC.; BAUSCH & LOMB CHINA, INC.; BAUSCH & LOMB INTERNATIONAL, INC.; BAUSCH & LOMB REALTY CORPORATION; BAUSCH & LOMB SOUTH ASIA, INC.; BAUSCH & LOMB TECHNOLOGY CORPORATION; IOLAB CORPORATION; RHC HOLDINGS, INC.; SIGHT SAVERS, INC.; WILMINGTON MANAGEMENT CORP.; WILMINGTON PARTNERS L.P.; B&L MINORITY DUTCH HOLDINGS LLC; EYEONICS, INC.
To: CREDIT SUISSE AG
Reel/Frame 024380/0286 →
SECURITY AGREEMENT Recorded Nov 16, 2007
From: BAUSCH & LOMB INCORPORATED; B&L CRL INC.; B&L CRL PARTNERS L.P.; B & L DOMESTIC HOLDINGS CORP.; B&L FINANCIAL HOLDINGS CORP.; B&L SPAF INC.; B&L VPLEX HOLDINGS, INC.; BAUSCH & LOMB CHINA, INC.; BAUSCH & LOMB INTERNATIONAL INC.; BAUSCH & LOMB TECHNOLOGY CORPORATION; BAUSCH & LOMB REALTY CORPORATION; BAUSCH & LOMB SOUTH ASIA, INC.; SIGHT SAVERS, INC.; WILMINGTON MANAGEMENT CORP.; WILMINGTON PARTNERS L.P.; B&L MINORITY DUTCH HOLDINGS LLC; IOLAB CORPORATION; RHC HOLDINGS, INC.; WP PRISM, INC.
To: CREDIT SUISSE
Reel/Frame 020122/0722 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2007
From: LAI, YU-CHIN, MR.; LANG, WEIHONG, MS.; QUINN, EDMOND T., MR.
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 019429/0676 →